Used in pharmaceutical research as a potent and selective inhibitor targeting specific kinase pathways involved in inflammatory and autoimmune diseases. Demonstrates high efficacy in modulating immune responses in preclinical models, making it a candidate for development in treatments for conditions such as rheumatoid arthritis and psoriasis. Its formulation in bis(4-methylbenzenesulfonate) salt enhances solubility and bioavailability, supporting oral dosing in experimental therapies. Also employed as a reference compound in pharmacokinetic and metabolic stability studies due to its well-defined activity and structural complexity.